Sylvester Comprehensive Cancer Center

International Breast Cancer Conference Attracts Specialists From 36 Countries

08.17.2006

Top oncologists, gynecologists, and healthcare administrators from around the world had an opportunity to exchange ideas and discuss promising new treatments at the 3rd InterAmerican Breast Cancer Conference in Cancun, Mexico. Nearly 400 attendees participated in a global exchange of the most promising future strategies for the management of breast cancer. The conference chair, Orlando Silva, M.D., J.D., F.A.C.P., member of the Braman Family Breast Cancer Institute at the University of Miami Sylvester Comprehensive Cancer Center, director of breast cancer education, and assistant professor of clinical medicine at the University of Miami Leonard M. Miller School of Medicine, was pleased with the quality of the conference. “The conference was everything we expected and more,” said Silva. “We had the top speakers from 36 different nations, including Europe, the U.S., and Latin America.” Silva’s co-chair was Stefan Glück, M.D., Ph.D., F.R.C.P. ©, clinical director of the Braman Family Breast Cancer Institute at UM/Sylvester, and professor of medicine, Miller School of Medicine, associate division chief clinical affairs, Division of Hematology Oncology.

Participants were given the opportunity to discuss the latest developments in surgery, radiation therapy, and systemic therapy for breast cancer. “It was of great distinction to have the father of breast cancer therapy Umberto Veronesi, M.D. from the European Institute of Oncology, in Milan Italy, who is currently up for the Nobel Prize for Medicine in 2006 with us,” said Silva. “We also enjoyed the company of distinguished guest Gabriel N. Hortobagyi, M.D., F.A.C.P. president of the American Society of Clinical Oncology, and Dennis J. Slamon, M.D., Ph.D. of UCLA, who discovered herceptin.” Among UM/Sylvester physicians and scientists in attendance were Joyce M. Slingerland, M.D., Ph.D., F.R.C.P. ©, director of the Braman Family Breast Cancer Institute at UM/Sylvester, Frederick L. Moffat, M.D., Eli Avisar, M.D., F.A.C.S., Carmen Gomez-Fernandez, M.D., Judith Hurley, M.D., Dido Franceschi, M.D., Joseph D. Rosenblatt, M.D., and Cristiane Takita, M.D.

The conference is held every two years. This year’s keynote speaker, the very distinguished Dennis J. Slamon, M.D., Ph.D., from the David Geffen School of Medicine at University of California, Los Angeles, presented, “The future of breast cancer: A visionary’s view.” “The quality of the conference was second to none and among the attendees there was great satisfaction about the quality of the lectures,” said Silva. “We take what we have learned back to our respective centers and apply it. I’m already looking forward to planning for the next conference.”

E-mail a Friend